down arrow

CellSource Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
481.00
-1 (-0.21%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Towa Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd.
Elan Corp.
Earth Corp.
ASKA Pharmaceutical Holdings Co., Ltd.
Zeria Pharmaceutical Co., Ltd.
Katakura Industries Co., Ltd.
KYORIN Pharmaceutical Co., Ltd.
CellSource Co., Ltd.
Torii Pharmaceutical Co., Ltd.
Nxera Pharma Co., Ltd.
Why is CellSource Co., Ltd. ?
1
The company has declared Negative results for the last 6 consecutive quarters
  • NET SALES(HY) At JPY 1,820.5 MM has Grown at -18.28%
  • NET PROFIT(HY) At JPY 4.82 MM has Grown at -98.38%
  • ROCE(HY) Lowest at -0.84%
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -53.03%, its profits have fallen by -95.7%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -53.03% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CellSource Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
CellSource Co., Ltd.
-53.03%
-1.58
38.36%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
18.65%
EBIT Growth (5y)
-173.68%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.84
Tax Ratio
58.23%
Dividend Payout Ratio
41.61%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
115.51%
ROE (avg)
16.13%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
357
Industry P/E
Price to Book Value
2.28
EV to EBIT
-66.17
EV to EBITDA
304.89
EV to Capital Employed
5.64
EV to Sales
2.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.52%
ROE (Latest)
0.64%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
PRE-TAX PROFIT(Q)

At JPY 77.63 MM has Grown at 2,284.46%

NET PROFIT(Q)

At JPY 54.65 MM has Grown at 480.37%

INVENTORY TURNOVER RATIO(HY)

Highest at 7.53%

OPERATING PROFIT MARGIN(Q)

Highest at 12.91 %

-18What is not working for the Company
NET SALES(HY)

At JPY 1,820.5 MM has Grown at -18.28%

NET PROFIT(HY)

At JPY 4.82 MM has Grown at -98.38%

ROCE(HY)

Lowest at -0.84%

RAW MATERIAL COST(Y)

Grown by 8.95% (YoY

Here's what is working for CellSource Co., Ltd.
Pre-Tax Profit
At JPY 77.63 MM has Grown at 2,284.46%
over average net sales of the previous four periods of JPY 3.26 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 54.65 MM has Grown at 480.37%
over average net sales of the previous four periods of JPY 9.42 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (JPY MM)

Operating Profit Margin
Highest at 12.91 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Inventory Turnover Ratio
Highest at 7.53%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for CellSource Co., Ltd.
Net Sales
At JPY 1,820.5 MM has Grown at -18.28%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (JPY MM)

Raw Material Cost
Grown by 8.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."